Isofol Medical Investor Relations Material
Latest events
Investor Update
Isofol Medical
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Isofol Medical
Access all reports
Segment Data
Access more data
Revenue by
Geography
Asia
Expenses by
Financials
Isofol Medical operates as a clinical stage biotech company that develops and commercializes oncology drugs. Its products include arfolitixorin, which is in phase 3 clinical trial for the treatment of colorectal cancer; pentosan sulfate sodium, which has completed a phase 2 clinical trial for ovarian cancer or recurrent bladder cancer indication; new chemical entities, preclinical NCEs; monoclonal antibodies, which are being investigated for immunotherapy treatment of different types of cancer.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
ISOFOL
Country
🇸🇪 Sweden